ST. LOUIS (
) -- Generic drugs boosted pharmacy benefit manager
The slight 1.1% increase led the company to raise its full-year guidance, sending shares up 2% to $73.15 in after-market trading.
During the quarter, Express Scripts earned $192.3 million, or 75 cents a share, compared with $190.2 million, or 76 cents, in the year-ago period.
Excluding expenses related to the acquisition of WellPoint's pharmacy benefit management business, earnings were actually 88 cents a share, beating Wall Street's forecast by a penny.
Revenue dropped slightly to $5.5 billion from $5.53 billion last year.
Looking forward, the company now expects full-year earnings in the range of $3.72 to $3.82 a share, up from prior forecast of $3.67 to $3.77 a share.
to $693.5 million, or $1.43 per share, from $750.5 million, or $1.44 per share in the year-earlier period, as it battles rising unemployment numbers.
Express Script's rival
said last week that its
in the second quarter despite a decrease in commercial enrollment.
-- Reported by Jeanine Poggi in New York.
Copyright 2009 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.